Her main research concerns Neuroscience, Brain-derived neurotrophic factor, Neurotrophic factors, Antidepressant and Hippocampus. Neuroscience is often connected to Long-term potentiation in her work. Her Brain-derived neurotrophic factor research is multidisciplinary, relying on both Endocrinology, Desipramine, Prefrontal cortex, Tropomyosin receptor kinase B and Neuroplasticity.
Her Neurotrophic factors study is concerned with the field of Internal medicine as a whole. Her studies examine the connections between Antidepressant and genetics, as well as such issues in NMDA receptor, with regards to Major depressive disorder, Ketamine and Receptor antagonist. Lisa M. Monteggia works mostly in the field of Hippocampus, limiting it down to topics relating to Neurotrophin and, in certain cases, Dentate gyrus, Postmortem studies and Mood disorders.
Lisa M. Monteggia focuses on Neuroscience, Neurotransmission, Synaptic plasticity, Brain-derived neurotrophic factor and Neurotrophic factors. Particularly relevant to Antidepressant is her body of work in Neuroscience. She combines subjects such as Molecular biology, Postsynaptic potential and Excitatory postsynaptic potential with her study of Neurotransmission.
Her research integrates issues of Synapse, Knockout mouse, Epigenetics and DNA methylation in her study of Synaptic plasticity. The Brain-derived neurotrophic factor study which covers Endocrinology that intersects with Nicotinic agonist. Lisa M. Monteggia interconnects Hippocampus, Prefrontal cortex and Desipramine in the investigation of issues within Neurotrophic factors.
Lisa M. Monteggia spends much of her time researching Neuroscience, Neurotransmission, NMDA receptor, Genetics and Long-term potentiation. Her Neuroscience study incorporates themes from Synaptic plasticity, Knockout mouse, Tropomyosin receptor kinase B, Brain-derived neurotrophic factor and Rett syndrome. Her studies deal with areas such as Endocrinology and Hippocampus as well as Synaptic plasticity.
Tropomyosin receptor kinase B is a subfield of Neurotrophic factors that Lisa M. Monteggia investigates. Lisa M. Monteggia has researched Neurotransmission in several fields, including Postsynaptic potential and Nervous system. Her work deals with themes such as Glutamate receptor, Glutamatergic, Ketamine, Antidepressant and Pharmacology, which intersect with NMDA receptor.
Lisa M. Monteggia mostly deals with Neuroscience, NMDA receptor, Ketamine, Antidepressant and Synaptic plasticity. The various areas that she examines in her Neuroscience study include Gene knockout and Knockout mouse. The study incorporates disciplines such as Metabolite, Glutamatergic, Pharmacology and Neurotransmission in addition to Ketamine.
In her study, Hippocampal formation and Hippocampus is strongly linked to Antagonist, which falls under the umbrella field of Pharmacology. Antidepressant is frequently linked to Brain-derived neurotrophic factor in her study. Her biological study spans a wide range of topics, including AMPA receptor, Endocrinology and Tropomyosin receptor kinase B.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neurobiology of depression.
Eric J. Nestler;Michel Barrot;Ralph J. DiLeone;Amelia J. Eisch.
A neurotrophic model for stress-related mood disorders.
Ronald S. Duman;Lisa M. Monteggia.
Biological Psychiatry (2006)
Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress
Olivier Berton;Colleen A. McClung;Ralph J. DiLeone;Vaishnav Krishnan.
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry;Megumi Adachi;Elena D Nosyreva;Elisa S. Na.
Brain-Derived Neurotrophic Factor and Neuropsychiatric Disorders
Anita E. Autry;Lisa M. Monteggia.
Pharmacological Reviews (2012)
Essential role of brain-derived neurotrophic factor in adult hippocampal function
Lisa M. Monteggia;Michel Barrot;Craig M. Powell;Olivier Berton.
Proceedings of the National Academy of Sciences of the United States of America (2004)
BDNF - a key transducer of antidepressant effects.
Carl Björkholm;Lisa M. Monteggia.
Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.
Lisa M. Monteggia;Bryan Luikart;Michel Barrot;David Theobold.
Biological Psychiatry (2007)
Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia
Takanori Hashimoto;Sarah E. Bergen;Quyen L. Nguyen;Baoji Xu.
The Journal of Neuroscience (2005)
Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.
Megumi Adachi;Michel Barrot;Anita E. Autry;David Theobald.
Biological Psychiatry (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: